Brunel University Research Archive(BURA) preserves and enables easy and open access to all
types of digital content. It showcases Brunel's research outputs.
Research contained within BURA is open access, although some publications may be subject
to publisher imposed embargoes. All awarded PhD theses are also archived on BURA.
Browsing by Subject access to medicines
Showing results 1 to 9 of 9
Issue Date | Title | Author(s) |
23-Mar-2023 | Access Denied: the Role of Trade Secrets in Preventing Global Equitable Access to COVID-19 Tools | Gurgula, O; McDonagh, L |
15-Aug-2020 | AI-assisted inventions in the field of drug discovery: readjusting the inventive step analysis | Gurgula, O |
6-Jun-2021 | COVID-19, IP and access: Will the current system of medical innovation and access to medicines meet global expectations? | Gurgula, O; Lee, WH |
1-Jun-2021 | Drug prices, patents and access to life-saving medicines: changes are urgently needed in the COVID-19 era | Gurgula, O |
28-Sep-2017 | Monopoly v. Openness: Two sides of IP coin in the pharmaceutical industry | Gurgula, O |
8-Oct-2020 | New anti-evergreening patent law in Ukraine | Gurgula, O |
1-Feb-2024 | On the European Commission’s proposal to create a new EU-wide compulsory licensing regime. | Gurgula, O |
28-Oct-2020 | Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene? | Gurgula, O |
16-Jun-2022 | Обмеження прав інтелектуальної власності під час війни для забезпечення доступу до критично необхідних ліків в Україні на підставі статті 73 ТРІПС | Gurgula, O |